![Chad Morin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chad Morin
Compliance Officer bei KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Aktive Positionen von Chad Morin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Compliance Officer | 01.10.2020 | - |
Karriereverlauf von Chad Morin
Ehemalige bekannte Positionen von Chad Morin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARIAD PHARMACEUTICALS, INC. | Compliance Officer | - | - |
BLUEBIRD BIO, INC. | Compliance Officer | - | - |
Ausbildung von Chad Morin
F.W. Olin Graduate School of Business | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Compliance Officer | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Kiniksa Pharmaceuticals Ltd.
![]() Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Chad Morin
- Erfahrung